Author: Dorron Blumberg

Last month, Aducanumab (Aduhelm™) was approved as a treatment for Alzheimer’s Disease by the U.S. Food and Drug Administration (FDA). This is the first FDA-approved therapy to potentially delay decline from the disease, compared to current medications that only address symptoms.

According to Matt Johnson, general manager of Century Ambulance Service, Inc., the company’s business in Florida for the past 20 years has been "pretty much the same – picking up patients and moving them to a new location." Then came COVID-19, and Johnson admitted, "That kind of created a pause in what we did, and we had to re-evaluate all of our practices."

With rising inflation and a shortage of cash, healthcare providers are looking for means of improving cashflow. The obvious but often missed monies are sitting on their books in accounts receivables—monies that health plans and payors have not paid, but the providers are entitled to.

Healthcare is always in a state of flux, and last year’s pandemic added more volatility to what is already a shifting landscape. Trying to keep up with all of the COVID regulatory changes, on top of the regular tax implications of running a business, is an overwhelming task without the help of professional accounting firms.